文献速递头颈外科

口咽鳞状细胞癌术后辅助治疗趋势

Trends in Adjuvant Therapy After Surgery for Oropharyngeal Squamous Cell Carcinoma.
PubMed 文献 · Laryngoscope · 2021-09-23

1年胃造瘘管依赖率从7.1%降至2.2%;两个时间段的2年总生存率和无病生存率无差异。

要点

  • HPV相关口咽癌术后辅助治疗率及辅助放化疗率随时间显著下降。
  • 2015至2019年患者1年胃造瘘管依赖率较2011至2014年显著降低。
  • 两个时间段2年总生存率和无病生存率无显著差异。

核心结论

  • 辅助治疗率(尤其是化疗)随时间下降。
  • 1年胃造瘘管依赖率从2011至2014年到2015至2019年显著下降。
  • 总生存率和无病生存率在此期间无变化。

研究设计与样本

  • 回顾性分析。

主要发现

  • 淋巴结外侵犯率从38.9%显著降至24.0%(P = .004)。
  • 辅助治疗率从90.9%显著降至62.5%(P = .001)。
  • 接受辅助治疗的患者中,辅助放化疗率从40.0%显著降至20.0%(P < .0005)。
  • 1年胃造瘘管依赖率2015至2019年为2.2%,2011至2014年为7.1%(P = .025)。

关键数值与推荐

  • 2011至2014年2年总生存率96%、无病生存率89%;2015至2019年分别为96%和94%。
  • 两个时间段总生存率和无病生存率无差异。

临床怎么用

  • HPV相关口咽癌经口机器人手术后辅助治疗率下降,需关注功能结局改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: We aim to 1) evaluate trends in adjuvant treatment of human papilloma virus (HPV)-related oropharyngeal cancer; 2) assess change in complications and functional outcomes over time; and 3) assess change in overall and disease-free survival (DFS) over time. STUDY DESIGN: Retrospective analysis. METHODS: Charts of patients who underwent transoral robotic surgery for HPV-related oropharyngeal cancer between 2011 and 2019 were reviewed. Trend analysis was used to compare rate of adjuvant treatment over time. The Kaplan-Meier method was conducted to analyze overall survival (OS) and DFS. RESULTS: Three hundred and forty-two patients met inclusion criteria. One hundred and sixty-three (47.7%) patients underwent adjuvant radiation, and 90 (26.3%) patients underwent adjuvant chemoradiation. Rate of extranodular extension decreased significantly from 38.9% to 24.0% (P = .004). Rate of adjuvant therapy decreased significantly from 90.9% to 62.5% between 2011 and 2019 (P = .001). In patients who received adjuvant treatment, rate of adjuvant chemoradiation therapy decreased significantly from 40.0% to 20.0% (P < .0005). There was a decrease in rate of 1-year gastrostomy tube dependence in patients treated in 2015 to 2019 versus 2011 to 2014 (2.2% vs. 7.1%, P = .025). In 2011 to 2014, 2-year OS and DFS were 96% and 89%, respectively; in 2015 to 2019, 2-year OS and DFS were 96% and 94%, respectively. There was no difference in OS or DFS between the two time periods. CONCLUSIONS: The rate of adjuvant therapy, particularly chemotherapy, has decreased over time. One-year gastrostomy tube dependence rate has decreased significantly from 2011 to 2014 to 2015 to 2019. There was no change in OS and DFS over this time period. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:806-812, 2022.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Philips R, Sagheer H, Barsouk A, et al. Trends in Adjuvant Therapy After Surgery for Oropharyngeal Squamous Cell Carcinoma. Laryngoscope. 2021. PMID: 34553790. doi:10.1002/lary.29870

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。